Prime Medicine, Inc. (NASDAQ: PRME) reported Q1 EPS of ($0.40), $0.04 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.